CVR 27047521Private limited company (ApS)Fremstilling af andre kemiske produkter i øvrigt (246600)Fruebjergvej 3, 2100 København ØFounded 26 Feb 2003
Employees
1
CVR, 2004
A-SYNTESE BIOTECH ApS
CVR registers no owner holding 5% or more.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about A-SYNTESE BIOTECH ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexCVR registers no owner holding 5% or more.
Anton Vyacheslavoich Dudinuntil 12 Dec 2005
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Q1 2005, quarterly: no employee count, 0 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 2004 | Q1 2005 |
|---|---|---|
| Employees | 1 | No count |
| FTE | 1 | 0 |
| Series | Annual | Quarterly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest Q1 2005, published 4 Oct 2005.
Not available in the CVR filing: the annual reports carry no machine-readable figures.
Annual report 2003
26 Feb 2003 to 31 Dec 2003, published 1 Jun 2004
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingNot read from the announcement | None | None | None | 125,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Source: CVR, read 20 Nov 2026.
6 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Konkursbehandlingen afsluttet 21.12.2006, selskabet opløst.
Konkursdekret afsagt 28.07.2006 af Sø- og Handelsrettens Skifteretsafdeling.
Den 07.12.2005 har Sø- og Handelsrettens Skifteretsafdeling udnævnt Advokat John Jakobsen, 2100 København Ø, til likvidator.
Selskabet tegnes af likvidator.
Anmodning om opløsning, jf. anpartsselskabslovens § 60, jf. § 61 sendt til Sø- og Handelsrettens Skifteretsafdeling den 26.08.2005.
Vedtægter ændret:
31.03.2003.
Nyt navn:
A-SYNTESE BIOTECH ApS.
Ny adresse:
c/o Symbion Science Park Box nr. 45, Fruebjergvej 3, 2100 København Ø.
Bestyrelse:
Indtrådt i bestyrelsen:
Direktør Anton Vyacheslavoich Dudin (formand), den 31.03.2003, Seniorforsker Nikolay Yevgenyevich Agafonov, den 31.03.2003, IT-Specialist Aleksey Alekseyevich Preobrazhenskiy, den 31.03.2003.
Direktion:
Udtrådt af direktionen:
Kim Madsen, den 31.03.2003.
Indtrådt i direktionen:
Direktør Anton Vyacheslavoich Dudin (adm. dir), den 31.03.2003.
Selskabet tegnes af en direktør.
Revision:
Udtrådt af revisionen:
ERNST & YOUNG STATSAUTORISERET REVISIONSAKTIESELSKAB, den 31.03.2003.
Indtrådt i revisionen:
CVR-NR. 39746115 KPMG DANMARK STATSAUTORISERET REVISIONSAKTIESELSKAB, Borups Alle 177, postboks 250, 2000 Frederiksberg, den 31.03.2003.
Stiftelsesdato:
26.02.2003.
Seneste vedtægtsdato:
26.02.2003.
Kapital:
kr. 125.000,00.
Indbetalingsmåde:
kontant kr. 125.000,00 til kurs 100,00.
Stifter:
CVR-NR. 13469938 VX 20.182 ApS, Kronprinsessegade 18, 1306 København K, den 26.02.2003.
Direktion:
Kim Madsen (adm. dir), den 26.02.2003.
Selskabet tegnes af den samlede bestyrelsen eller af et bestyrelsesmedlem i forening med en direktør.
Revision:
ERNST & YOUNG STATSAUTORISERET REVISIONSAKTIESELSKAB, Ny Østergade 11, 4000 Roskilde, den 26.02.2003.
Første regnskabsår:
26.02.2003 - 31.12.2003.
Regnskabsår:
01.01 - 31.12.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 20 Nov 2026.
What Pro holds for A-SYNTESE BIOTECH ApS:
Have Pro? Sign in.
P-number 1009739005Fruebjergvej 3, 2100 København Ø